Morning Overview on MSN
How science and luck sparked a radical new era in schizophrenia treatment
The U.S. Food and Drug Administration approved Cobenfy on September 26, 2024, making it the first schizophrenia drug with a ...
Demonstrated 98% increase in average flight time versus mass-produced Chinese battery benchmark via live drone field test Achieved 50% faster charging rates from silicon anode integration & improved ...
Revenue: During the fourth quarter, revenue increased to $2,023.0 million, compared with $1,415.8 million during Q4 2024. Revenue increased to $7,051.1 million for full-year 2025, compared with $5,148 ...
Delivered on all key guidance metrics, maintains three-year outlook of 2.0 million Au eq. oz. per yearRecord free cash flow of $2.5 billion and ...
Know why security failures are more damaging in cross-chain systems. Learn how bridge complexity, shared trust assumptions, and liquidity contagion multiply risks in the blockchain ecosystem.
Shareholder/Analyst Call February 17, 2026 7:30 PM ESTCompany ParticipantsPatrick Redmond O'SullivanEdward Chung - CEO, ...
Mineros S.A. (TSX:MSA, OTCQX:MNSAF, BVC:MINEROS) ("Mineros" or the "Company") today reported its financial and operating results for the three months and year ended December 31, 2025. All dollar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results